
Laxmi Dental Limited: Q3 & 9M FY26 Consolidated Results
Mumbai: Laxmi Dental Limited (BSE – 544339, NSE – LAXMIDENTL), a leading integrated dental products company, announced its unaudited Financial Results for the
Be Ahead With Economy And Policy Updates

Mumbai: Laxmi Dental Limited (BSE – 544339, NSE – LAXMIDENTL), a leading integrated dental products company, announced its unaudited Financial Results for the

Mumbai: Wanbury Ltd, a pharmaceutical company with a presence in the global API market and domestic branded formulations, has announced its financial results for

Hyderabad: NATCO Pharma Limited (BSE: 524816 and NSE: NATCOPHARM) (“NATCO”) received tentative approval from the U.S. FDA for Erdafitinib, 3 mg, 4mg, and 5

Ahmedabad: Shelter has spent the last six decades championing natural healing, guided by the principles of tradition, integrity, and continuous progress. Today Shelter stands

Mumbai: Wockhardt announced that its novel intravenous antibiotic Foviscu® (WCK 4282) has successfully met the primary endpoint in a Phase 3 clinical trial in

Greater Noida: France will ban social media use for the children under 15 years old. This ban may take effect from the next

Bengaluru: The merger between Aster DM Healthcare Limited, and Quality Care India Ltd, one of the largest merger announcements in the healthcare industry

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”), an innovation-led life-sciences company with an international presence has launched the world’s

Bengaluru: Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, today announced the successful completion of a Qualified Institutions Placement

Ahmedabad: Sentynl Therapeutics Inc. (“Sentynl”), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences Limited (“Zydus Group”), announced that the U.S. Food and Drug
Newsletter

Persistent Wins CII Award for Excellence in Disability Inclusion

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg

BCPL Railway Infra Bags Rs. 46.18 Million Work Under Sealdah Division of Eastern Railway

Intense Technologies Announces Retirement of Founder C.K. Shastri

ACS Technologies Achieves CMMI Maturity Level 3 Appraisal For DEV and SVC Domains
